Reneo Pharmaceuticals, Inc. RPHM
18.20 +18.20
Day range unavailable
52-week range unavailable
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -83.05M | -53.85M | -39.82M | -19.55M | -15.47M | |
| -77.39M | -51.95M | -39.77M | -19.46M | -12.44M | |
| -2.52 | -2.12 | -2.19 | -9.60 | -6.38 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 27.63M | 19.93M | 124.66M | 53.61M | 17.50M | |
| 107.44M | 108.18M | 154.02M | 55.22M | 25.50M | |
| 18.83M | 8.21M | 6.81M | 4.62M | 2.98M | |
| 973.00K | 1.46M | 0 | 0 | 0 | |
| 88.61M | 99.97M | 147.21M | -42.12M | -23.13M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -63.68M | -47.36M | -37.98M | -18.54M | -12.51M | |
| 10.52M | -57.84M | -23.38M | 7.38M | -7.24M | |
| 60.87M | 471.00K | 132.41M | 47.27M | 24.99M | |
| -221.00K | -346.00K | -198.00K | -24.00K | -7.00K | |
| 7.71M | -104.73M | 71.05M | 36.11M | 5.24M |